Last updated: January 30, 2024
Sponsor: University Hospital, Ghent
Overall Status: Active - Recruiting
Phase
N/A
Condition
Peyronie's Disease
Enuresis
Treatment
Free graft urethroplasty
Clinical Study ID
NCT04551417
BC-06890
Ages > 18 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Voluntarily signed written informed consent according to the rules of Good ClinicalPractice (Declaration of Helsinki) and national regulations (Appendix B).
- Age ≥ 18 years.
- Male patient.
- Fit for operation, based on the surgeon's expert opinion.
- Isolated bulbar urethral stricture confirmed by imaging.
- Preputium, penile shaft skin, buccal mucosa and lingual mucosa are allowed as freegraft material in the executed dorsal onlay or ventral onlay FGU.
- Patient is able and willing to attend the follow-up consultations.
Exclusion
Exclusion Criteria:
- Absence of signed written informed consent (Appendix B).
- Age < 18 years.
- Female patients.
- Transgender patients.
- Patients unfit for operation.
- Concomitant urethral strictures at other urethral locations (penile urethra,membranous urethra, prostatic urethra, bladder neck).
- A unique urethral stricture at other urethral locations (penile urethra, membranousurethra, prostatic urethra, bladder neck).
- Prior bulbar urethroplasty.
- Lichen Sclerosus related strictures.
- Strictures after failed hypospadias repair.
- Patients with neurogenic bladder.
- History of pelvic radiation therapy.
- Shift of technique to any other technique than dorsal or ventral onlay FGU due to anycircumstance (post-hoc exclusion).
- Utilization of free graft material other than preputium, penile shaft skin, buccalmucosa or lingual mucosa.
- Any condition or situation, which, in the investigator's opinion, puts the patient atsignificant risk, could confound the study results, or may interfere significantlywith the patient's participation in the study.
- Patient declares that it will be impossible for him to attend the follow-upconsultations.
Study Design
Total Participants: 240
Treatment Group(s): 1
Primary Treatment: Free graft urethroplasty
Phase:
Study Start date:
March 04, 2020
Estimated Completion Date:
January 01, 2026
Study Description
Connect with a study center
Ghent University Hospital
Ghent, 9000
BelgiumActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.